Status:
COMPLETED
Comparison of Tetracaine 0.5% and Lidocaine 2% Jelly for Topical Phacoemulsification Cataract Surgery
Lead Sponsor:
Hermann Eye Center
Conditions:
Cataracts
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine if there is a difference on the penetration of betadine 5% when using lidocaine 2% jelly versus topical tetracaine 0.5% in topical cataract surgery. This will...
Detailed Description
The purpose of this research study is to show that using Lidocaine2% jelly before surgery as an anesthetic (keep you from feeling touch or pain) for cataract surgery does not block the antiseptic (cle...
Eligibility Criteria
Inclusion
- greater or equal to 18 years old
- uni- or bi-lateral visually significant cataracts
Exclusion
- hypersensitivity to betadine5%, topical tetracaine0.5%, or lidocaine2% jelly
- pregnancy
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00827073
Start Date
November 1 2008
End Date
July 1 2010
Last Update
July 22 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Hermann Plaza Surgery Center
Houston, Texas, United States, 77030